Hexima CEO, Michael Aldridge, presented at the ShareCafe Hidden Gems Webinar on 29 April 2022 at 12:30pm AEST. Mr Aldridge provided a company...
ShareCafe Webinar 29 April 2022
read more
Webinars & Events
Investor Webinar April 2022
Thank you to those that attended our Investor Webinar today, 5 April 2022 at 9:00 AM AEST. Hexima Chief Operating Officer, Dr Nicole van der...
Hexima featured at Edison Global Healthcare 2022
Hexima was pleased to be featured at Edison Open House: Global Healthcare 2022. Edison Group is an investment research, investor relations and...
Annual General Meeting 2021
The Hexima Limited Annual General meeting was held on 2 December 2021 at 11am. A copy of the CEO presentation and a recording of the meeting are...
The Market Herald Interview
Hexima's CEO, Mr Michael Aldridge spoke to Sonia Madigan on The Deal Room by The Market Herald regarding its recent capital raise and what to expect...
Hexima Presenting at AusBiotech
Mr Michael Aldridge, CEO of Hexima, presented today at AusBiotech’s “Australia Biotech Invest & Partnering Conference 2021”. AusBiotech is the...
Review of FY21 – Investor Webinar
Watch Hexima's CEO, Mr Michael Aldridge, review the achievements of FY21 and inform investors of expected important developments and milestones....
Consumer Centric Investor Webinar
Watch Hexima CEO, Mr Michael Aldridge, and Hexima's Commercial Consultant, Mr Phil Rose, discuss how Hexima is taking a consumer-centric view on...
Presentation of Phase I/IIa study data at American Podiatric Medical Association (APMA) and Investor Webinar
Joining the annual APMA 2021 Annual Scientific Meeting held from July 29 to August 1, was an important opportunity to share Hexima’s data on...
Media Interview and Presentation – Stockhead
Hexima CEO, Michael Aldrige, spoke with Stockhead as part of their V-Con video conference series focused on biotechs. V-Con is Stockhead’s investing...